NSE、S-100蛋白与脑损伤关系的研究

[1] S100B and NSE serum levels in obstructive sleep apnea syndrome [J]. SLEEP MEDICINE, 2006, 7 (05) : 431 - 435

[2] Neuronal apoptosis following human brain injury [J]. INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2004, 118 (01) : 32 - 36

[3] Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients [J]. BRAIN RESEARCH BULLETIN, 2003, 61 (03) : 261 - 264

[4] Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern [J]. BRAIN RESEARCH BULLETIN, 2003, 61 (03) : 281 - 285

[5] Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.[J].Elaine R Peskind;W.Sue T Griffin;Keith T Akama;Murray A Raskind;Linda J Van Eldik.Neurochemistry International.2001, 5

[6] Neuronal and astroglial injuries in patients undergoing coronary artery bypass grafting and aortic arch replacement during hypothermic cardiopulmonary bypass [J]. ANESTHESIA AND ANALGESIA, 2000, 91 (05) : 1066 - 1072

[7] Serum S-100 Protein; Relationship to Clinical Outcome in Acute Stroke.[J].Hagosa D Abraha;Richard J Butterworth;Philip M W Bath;Wassif S Wassif;John Garthwaite;Roy A Sherwood.Annals of Clinical Biochemistry.1997, 5

[8] Chronic elevation of S100β protein does not alter APP mRNA expression or promote β-amyloid deposition in the brains of aging transgenic mice.[J].Jibin Yao;Cheryl Kitt;Roger H. Reeves.Brain Research.1995, 1

[9] S100 PROTEIN EXPRESSION IN SUBPOPULATIONS OF NEURONS OF RAT-BRAIN [J]. NEUROSCIENCE, 1995, 67 (04) : 977 - 991

[10] NEURON-SPECIFIC ENOLASE CONCENTRATIONS IN BLOOD AS A PROGNOSTIC PARAMETER IN CEREBROVASCULAR DISEASES [J]. STROKE, 1994, 25 (03) : 558 - 565

[1] S100B and NSE serum levels in obstructive sleep apnea syndrome [J]. SLEEP MEDICINE, 2006, 7 (05) : 431 - 435

[2] Neuronal apoptosis following human brain injury [J]. INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2004, 118 (01) : 32 - 36

[3] Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients [J]. BRAIN RESEARCH BULLETIN, 2003, 61 (03) : 261 - 264

[4] Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern [J]. BRAIN RESEARCH BULLETIN, 2003, 61 (03) : 281 - 285

[5] Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.[J].Elaine R Peskind;W.Sue T Griffin;Keith T Akama;Murray A Raskind;Linda J Van Eldik.Neurochemistry International.2001, 5

[6] Neuronal and astroglial injuries in patients undergoing coronary artery bypass grafting and aortic arch replacement during hypothermic cardiopulmonary bypass [J]. ANESTHESIA AND ANALGESIA, 2000, 91 (05) : 1066 - 1072

[7] Serum S-100 Protein; Relationship to Clinical Outcome in Acute Stroke.[J].Hagosa D Abraha;Richard J Butterworth;Philip M W Bath;Wassif S Wassif;John Garthwaite;Roy A Sherwood.Annals of Clinical Biochemistry.1997, 5

[8] Chronic elevation of S100β protein does not alter APP mRNA expression or promote β-amyloid deposition in the brains of aging transgenic mice.[J].Jibin Yao;Cheryl Kitt;Roger H. Reeves.Brain Research.1995, 1

[9] S100 PROTEIN EXPRESSION IN SUBPOPULATIONS OF NEURONS OF RAT-BRAIN [J]. NEUROSCIENCE, 1995, 67 (04) : 977 - 991

[10] NEURON-SPECIFIC ENOLASE CONCENTRATIONS IN BLOOD AS A PROGNOSTIC PARAMETER IN CEREBROVASCULAR DISEASES [J]. STROKE, 1994, 25 (03) : 558 - 565